The results showed that the proportion of CD8+ T cells was significantly lower in the TP53 mutant group than in the wild group and that TP53 mutations were weakly to moderately correlated with changes in the proportion of tumor-infiltrating immune cells and different subpopulations. The gene discussed is CD8A; the disease is neoplasm.